Menu
GeneBe

rs777676129

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4_SupportingPP5

The NM_000782.5(CYP24A1):c.428_430del(p.Glu143del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000526 in 1,613,766 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00051 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00053 ( 1 hom. )

Consequence

CYP24A1
NM_000782.5 inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:8U:1

Conservation

PhyloP100: 7.33
Variant links:
Genes affected
CYP24A1 (HGNC:2602): (cytochrome P450 family 24 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This mitochondrial protein initiates the degradation of 1,25-dihydroxyvitamin D3, the physiologically active form of vitamin D3, by hydroxylation of the side chain. In regulating the level of vitamin D3, this enzyme plays a role in calcium homeostasis and the vitamin D endocrine system. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_000782.5. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant 20-54172927-CCTT-C is Pathogenic according to our data. Variant chr20-54172927-CCTT-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 29677.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=7}. Variant chr20-54172927-CCTT-C is described in Lovd as [Likely_pathogenic]. Variant chr20-54172927-CCTT-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CYP24A1NM_000782.5 linkuse as main transcriptc.428_430del p.Glu143del inframe_deletion 2/12 ENST00000216862.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CYP24A1ENST00000216862.8 linkuse as main transcriptc.428_430del p.Glu143del inframe_deletion 2/121 NM_000782.5 P1Q07973-1
CYP24A1ENST00000395955.7 linkuse as main transcriptc.428_430del p.Glu143del inframe_deletion 2/111 Q07973-2
CYP24A1ENST00000472970.1 linkuse as main transcriptn.265_267del non_coding_transcript_exon_variant 2/23

Frequencies

GnomAD3 genomes
AF:
0.000512
AC:
78
AN:
152212
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.0198
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000735
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000529
AC:
133
AN:
251266
Hom.:
1
AF XY:
0.000552
AC XY:
75
AN XY:
135836
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000173
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.0000465
Gnomad NFE exome
AF:
0.00105
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000528
AC:
771
AN:
1461554
Hom.:
1
AF XY:
0.000541
AC XY:
393
AN XY:
727088
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.000201
Gnomad4 ASJ exome
AF:
0.000230
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000580
Gnomad4 FIN exome
AF:
0.0000754
Gnomad4 NFE exome
AF:
0.000630
Gnomad4 OTH exome
AF:
0.000580
GnomAD4 genome
AF:
0.000512
AC:
78
AN:
152212
Hom.:
0
Cov.:
33
AF XY:
0.000444
AC XY:
33
AN XY:
74366
show subpopulations
Gnomad4 AFR
AF:
0.0000724
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.000864
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000735
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.000955
Hom.:
0
Bravo
AF:
0.000718

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:8Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hypercalcemia, infantile, 1 Pathogenic:6
Pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityJan 11, 2023- -
Pathogenic, no assertion criteria providedliterature onlyOMIMNov 03, 2011- -
Pathogenic, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017The CYP24A1 c.428_430delAAG (p.Glu143del) variant is an in-frame deletion variant that is reported often in the literature. Across 14 studies, the variant was identified in a total of 25 individuals with infantile hypercalcemia, including 12 homozygotes and 13 compound heterozygotes, and in eight unaffected heterozygous family members of affected individuals (Schlingmann et al. 2011; Streeten et al. 2011; Dauber et al. 2012; Nesterova et al. 2013; Dinour et al. 2013; Wolf et al. 2014; Jacobs et al 2014; Dowen et al. 2014; Dinour et al. 2015; Figueres et al. 2015; Shah et al. 2015; Jobst-Schwan et al. 2015; Braun et al. 2016; Gigante et al. 2016). Segregation analysis was compatible with autosomal recessive inheritance. The variant was absent from at least 204 control alleles and is reported at a frequency of 0.00218 in the European American population of the Exome Sequencing Project. Functional studies in V79-4 Chinese hamster lung fibroblast cells showed that the p.Glu143del variant resulted in ablation of CYP24A1 catabolic activity (Schlingmann et al. 2011). Based on the collective evidence, the p.Glu143del variant is classified as pathogenic for infantile hypercalcemia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
Pathogenic, criteria provided, single submitterclinical testingMolecular Genetics, Royal Melbourne HospitalJan 05, 2024This sequence change is predicted to cause a change in the length of the protein due to an in-frame deletion of one amino acid in a non-repeat region of the CYP24A1 protein, p.(Glu143del). The region deleted is highly conserved (100 vertebrates, UCSC). The highest population minor allele frequency in the population database gnomAD v2.1 is 0.1% (131/129,132 alleles) in the European non-Finnish population. This variant has been reported in multiple individuals with idiopathic infantile hypercalcaemia in the homozygous and compound heterozygous state (PMID: 21675912, 34858904, 34551392, 34307984, 33099630, 34125233 ). The variant has been reported to segregate with idiopathic hypercalcaemia in affected family members (PMID: 21675912). An in vitro functional assay with limited validation showed a complete loss of enzyme activity (PMID: 21675912). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as PATHOGENIC. Following criteria are met: PM3_VeryStrong, PM4_Supporting, PS3_Supporting -
Pathogenic, criteria provided, single submitterclinical testingInstitute of Human Genetics Munich, Klinikum Rechts Der Isar, TU MünchenMar 07, 2023- -
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 23, 2023Variant summary: CYP24A1 c.428_430delAAG (p.Glu143del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. The variant allele was found at a frequency of 0.00053 in 251266 control chromosomes in the gnomAD database, including 1 homozygotes. c.428_430delAAG has been reported in the literature in multiple individuals affected with infantile hypercalcemia or adult hypercalcemia. These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and showed that this variant resulted in ablation of CYP24A1 catabolic activity (Schlingmann_2011). Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (pathogenic/likely pathogenic n=4, VUS n=1). Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:2Uncertain:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeJan 19, 2024This variant, c.428_430del, results in the deletion of 1 amino acid(s) of the CYP24A1 protein (p.Glu143del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs777676129, gnomAD 0.1%), including at least one homozygous and/or hemizygous individual. This variant has been observed in individual(s) with idiopathic infantile hypercalcemia and hypercalciuric nephrolithiasis (PMID: 21675912, 22047572, 22112808, 23293122, 23470222, 24423361, 24875559, 25194629, 26097993, 26304832, 26787776, 26846157, 27394135, 27639704). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 29677). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects CYP24A1 function (PMID: 21675912). For these reasons, this variant has been classified as Pathogenic. -
Uncertain significance, criteria provided, single submitterclinical testingMolecular Diagnostics Lab, Nemours Children's Health, DelawareFeb 27, 2015- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxApr 29, 2023Published functional studies demonstrate a damaging effect on enzyme activity (Schlingmann KP et al., 2011); In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34805638, 34320495, 22047571, 23293122, 23470222, 24875559, 25194629, 22047572, 26787776, 27639704, 26846157, 26304832, 26097993, 28324001, 28874334, 26501157, 29786188, 31028937, 31751313, 31980526, 26585929, 22112808, 31089432, 27394135, 21675912, 24518185, 24423361, 34426522, 31589614, 33099630, 33186763, 35569070, 28109821, 33502802, 34307984) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs777676129; hg19: chr20-52789466; API